Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Sclerostin inhibitor PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109572